PREAXIA HEALTH CARE PAYMENT SYSTEMS INC.
No SEC Form 4 filings for $PAXH in the last 30 days.
See all $PAXH insider activity →PREAXIA HEALTH CARE PAYMENT SYSTEMS INC. reported a Q1 2027 net loss of $206,876, with no revenue and a diluted loss per share of $0.004, improving from the year-ago quarter. The company is in development, focusing on launching its AI-powered personal finance and health-payments product, Zane, with initial market focus on Canada and planned U.S. expansion.
Over the past 7 days, AlphAI's AI scored 1 news story mentioning PAXH (PREAXIA HEALTH CARE PAYMENT SYSTEMS INC.). Coverage has skewed bearish: 0 bullish, 0 neutral, and 1 bearish.
Quarterly loss with no revenue suggests continued development stage and may pressure the stock lower.
AlphAI scores every news story that mentions PAXH with an AI model for sentiment and relevance, and aggregates insider trades from PREAXIA HEALTH CARE PAYMENT SYSTEMS INC.'s SEC EDGAR Form 4 filings. Figures refresh continuously.
PREAXIA HEALTH CARE PAYMENT SYSTEMS INC. reported a Q1 2027 net loss of $206,876, with no revenue and a diluted loss per share of $0.004, improving from the year-ago quarter. The company is in development, focusing on launching its AI-powered personal finance and health-payments product, Zane, with initial market focus on Canada and planned U.S. expansion.
1 min read
